Blue Water Life Science Advisors, LP - MAXCYTE INC ownership

MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 104 filers reported holding MAXCYTE INC in Q4 2022. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.

Quarter-by-quarter ownership
Blue Water Life Science Advisors, LP ownership history of MAXCYTE INC
ValueSharesWeighting
Q3 2023$5,881,200
-32.0%
1,885,0000.0%5.55%
-4.9%
Q2 2023$8,652,150
-45.8%
1,885,000
-41.6%
5.84%
-44.7%
Q1 2023$15,963,750
-9.3%
3,225,0000.0%10.56%
-10.8%
Q4 2022$17,608,500
-16.0%
3,225,0000.0%11.83%
+39.8%
Q3 2022$20,963,0003,225,0008.46%
Other shareholders
MAXCYTE INC shareholders Q4 2022
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 372,000$4,542,0004.32%
Casdin Capital, LLC 13,971,334$170,590,0004.25%
Montanaro Asset Management Ltd 2,549,000$30,996,0003.74%
HARBERT FUND ADVISORS, INC. 724,856$8,850,0003.14%
Nine Ten Capital Management LLC 1,900,968$23,211,0002.48%
RIVER GLOBAL INVESTORS LLP 2,305,500$27,978,0002.17%
Vitruvian Partners LLP 3,330,000$40,659,0001.70%
Nicholas Investment Partners, LP 980,122$11,967,0000.87%
First Light Asset Management, LLC 994,670$12,145,0000.80%
AREX Capital Management, LP 126,968$1,550,0000.72%
View complete list of MAXCYTE INC shareholders